FOURIER/EBBINGHAUS: So Far, So Good. But Can We Afford It?

Drs Harrington and Yancy review the efficacy and cognitive safety data for the PCSK9 inhibitor evolocumab, presented at the American College of Cardiology sessions.

Source: Medscape Cardiology Podcast - March 23, 2017 Category: Cardiology Authors: Medscape Source Type: podcasts